Abstract
19 tomoscintigraphies using gallium 67 were performed in 15 patients with Hodgkin's or non-Hodgkin's lymphoma who had a residual mass after treatment. The isotope was never fixed in fibrous masses but was always concentrated in actively growing masses. In five cases histology confirmed these findings. It is recommended that scintigraphy should be considered in every case with a residual mass after treatment, where a decision regarding further treatment is required.
MeSH terms
-
Abdominal Neoplasms / diagnostic imaging*
-
Abdominal Neoplasms / drug therapy
-
Abdominal Neoplasms / pathology
-
Abdominal Neoplasms / surgery
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Combined Modality Therapy
-
Follow-Up Studies
-
Gallium Radioisotopes*
-
Humans
-
Lymphoma / diagnostic imaging*
-
Lymphoma / drug therapy
-
Lymphoma / pathology
-
Lymphoma / surgery
-
Neoplasm Recurrence, Local / diagnostic imaging*
-
Remission Induction
-
Thoracic Neoplasms / diagnostic imaging*
-
Thoracic Neoplasms / drug therapy
-
Thoracic Neoplasms / pathology
-
Thoracic Neoplasms / surgery
-
Tomography, Emission-Computed*